Clovis shares double on positive early data for lung cancer drug
Jun 4, 2013 | e-insurance.ws
– Clovis Oncology said initial results of an early-stage trial of its experimental lung cancer drug showed a reduction in tumor size, prompting investors to more than double the company's market value on Monday. The...
Read more...
All similar articles: 60 »
Clovis lung cancer drug double experimental ther Uncategorized